Novel pharmacologic therapies for cystic fibrosis

This publication has 45 references indexed in Scilit:

• Direct Activation of Cystic Fibrosis Transmembrane Conductance Regulator Channels by 8-Cyclopentyl-1,3-dipropylxanthine (CPX) and 1,3-Diallyl-8-cyclohexylxanthine (DAX)
  Published by Elsevier ,1998
• The Molecular Chaperone Hsc70 Assists the in VitroFolding of the N-terminal Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator
  Published by Elsevier ,1997
• The Final Stage of Gene Expression: Chaperones and the Regulation of Protein Fate
  American Journal of Human Genetics, 1997
• Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
  Cell, 1996
• Phosphorylation-dependent Block of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel by Exogenous R Domain Protein
  Published by Elsevier ,1996
• Triple-barrel Organization of ENaC, a Cloned Epithelial Na+ Channel
  Published by Elsevier ,1996
• Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation
  Journal of Biological Chemistry, 1996
• A1 Receptor Antagonist 8-Cyclopentyl-1,3-dipropylxanthine Selectively Activates Chloride Efflux from Human Epithelial and Mouse Fibroblast Cell Lines Expressing the Cystic Fibrosis Transmembrane Regulator .DELTA.F508 Mutation
  Biochemistry, 1995
• Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells.
  Journal of Clinical Investigation, 1994
• Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation
  Nature, 1991